1. Home
  2. EVV vs CSTL Comparison

EVV vs CSTL Comparison

Compare EVV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Limited Duration Income Fund of Beneficial Interest

EVV

Eaton Vance Limited Duration Income Fund of Beneficial Interest

HOLD

Current Price

$9.91

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$40.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVV
CSTL
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVV
CSTL
Price
$9.91
$40.31
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$46.00
AVG Volume (30 Days)
323.7K
333.2K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$343,530,000.00
Revenue This Year
N/A
$2.54
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.15
52 Week Low
$8.52
$14.59
52 Week High
$10.07
$42.18

Technical Indicators

Market Signals
Indicator
EVV
CSTL
Relative Strength Index (RSI) 40.70 57.91
Support Level $9.94 $38.73
Resistance Level $10.01 $41.60
Average True Range (ATR) 0.05 1.58
MACD -0.00 -0.12
Stochastic Oscillator 14.29 62.75

Price Performance

Historical Comparison
EVV
CSTL

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: